Your browser doesn't support javascript.
Emergence of the delta variant and risk of SARS-CoV-2 infection in secondary school students and staff: Prospective surveillance in 18 schools, England.
Ladhani, Shamez N; Ireland, Georgina; Baawuah, Frances; Beckmann, Joanne; Okike, Ifeanyichukwu O; Ahmad, Shazaad; Garstang, Joanna; Brent, Andrew J; Brent, Bernadette; Aiano, Felicity; Amin-Chowdhury, Zahin; Kall, Meaghan; Borrow, Ray; Linley, Ezra; Zambon, Maria; Poh, John; Warrener, Lenesha; Lackenby, Angie; Ellis, Joanna; Amirthalingam, Gayatri; Brown, Kevin E; Ramsay, Mary E.
  • Ladhani SN; Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, 61 Colindale Avenue, London NW9 5EQ, UK.
  • Ireland G; Paediatric Infectious Diseases Research Group, St. George's University of London, London SW17 0RE, UK.
  • Baawuah F; Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, 61 Colindale Avenue, London NW9 5EQ, UK.
  • Beckmann J; Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, 61 Colindale Avenue, London NW9 5EQ, UK.
  • Okike IO; East London NHS Foundation Trust, 9 Alie Street, London E1 8DE, UK.
  • Ahmad S; Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, 61 Colindale Avenue, London NW9 5EQ, UK.
  • Garstang J; University Hospitals of Derby and Burton NHS Foundation Trust, 201 London Road, Derby DE1 2TZ, UK.
  • Brent AJ; Manchester University NHS Foundation Trust, Oxford Road, Manchester M13 9WL, UK.
  • Brent B; Birmingham Community Healthcare NHS Trust, Holt Street, Aston B7 4BN, UK.
  • Aiano F; Nuffield Department of Medicine, Oxford University Hospitals NHS Foundation Trust, Old Road, Oxford OX3 7HE, UK.
  • Amin-Chowdhury Z; University of Oxford, Wellington Square, Oxford OX1 2JD, UK.
  • Kall M; University of Oxford, Wellington Square, Oxford OX1 2JD, UK.
  • Borrow R; Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, 61 Colindale Avenue, London NW9 5EQ, UK.
  • Linley E; Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, 61 Colindale Avenue, London NW9 5EQ, UK.
  • Zambon M; Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, 61 Colindale Avenue, London NW9 5EQ, UK.
  • Poh J; UK Health Security Agency, Manchester Royal Infirmary, Manchester, UK.
  • Warrener L; UK Health Security Agency, Manchester Royal Infirmary, Manchester, UK.
  • Lackenby A; Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, 61 Colindale Avenue, London NW9 5EQ, UK.
  • Ellis J; Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, 61 Colindale Avenue, London NW9 5EQ, UK.
  • Amirthalingam G; Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, 61 Colindale Avenue, London NW9 5EQ, UK.
  • Brown KE; Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, 61 Colindale Avenue, London NW9 5EQ, UK.
  • Ramsay ME; Immunisation and Vaccine Preventable Diseases Division, UK Health Security Agency, 61 Colindale Avenue, London NW9 5EQ, UK.
EClinicalMedicine ; 45: 101319, 2022 Mar.
Article in English | MEDLINE | ID: covidwho-1704577
ABSTRACT

BACKGROUND:

The role of educational settings in SARS-CoV-2 infection and transmission remains controversial. We investigated SARS-CoV-2 infection, seroprevalence, and seroconversion rates in secondary schools during the 2020/21 academic year, which included the emergence of the more transmissible alpha and delta variants, in England.

METHODS:

The UK Health Security Agency (UKHSA) initiated prospective surveillance in 18 urban English secondary schools. Participants had nasal swabs for SARS-CoV-2 RT-PCR and blood sampling for SARS-CoV-2 nucleoprotein and spike protein antibodies at the start (Round 1 September-October 2020) and end (Round 2 December 2020) of the autumn term, when schools reopened after national lockdown was imposed in January 2021 (Round 3 March-April 2021), and end of the academic year (Round 4 May-July 2021).

FINDINGS:

We enrolled 2314 participants (1277 students, 1037 staff; one participant had missing data for PCR testing). In-school testing identified 31 PCR-positive participants (20 students, 11 staff). Another 247 confirmed cases (112 students, 135 staff) were identified after linkage with national surveillance data, giving an overall positivity rate of 12.0% (278/2313; staff 14.1%, 146/1037 vs students 10.3%, 132/1276; p = 0.006). Trends were similar to national infection data. Nucleoprotein-antibody seroprevalence increased for students and staff between Rounds 1 and 3 but were similar between Rounds 3 and 4, when the delta variant was the dominant circulating strain. Overall, Nucleoprotein-antibody seroconversion was 18.4% (137/744) in staff and 18.8% (146/778) in students, while Spike-antibody seroconversion was higher in staff (72.8%, 525/721) than students (21.3%, 163/764) because of vaccination.

INTERPRETATION:

SARS-CoV-2 infection rates in secondary schools remained low when community infection rates were low, even as the delta variant was emerging in England.

FUNDING:

This study was funded by the UK Department of Health and Social Care.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study / Prognostic study Topics: Vaccines / Variants Language: English Journal: EClinicalMedicine Year: 2022 Document Type: Article Affiliation country: J.eclinm.2022.101319

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study / Prognostic study Topics: Vaccines / Variants Language: English Journal: EClinicalMedicine Year: 2022 Document Type: Article Affiliation country: J.eclinm.2022.101319